- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- April 2024
- 140 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- August 2022
- 689 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- January 2021
- 689 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- May 2020
- 275 Pages
Global
From €4657EUR$4,899USD£3,913GBP
- Report
- November 2021
- 88 Pages
Global
From €4706EUR$4,950USD£3,953GBP
Virus purification within biotechnology refers to the process of isolating viruses from samples that may contain proteins, nucleic acids, and other contaminants. This purification is critical in various applications including vaccine development, gene therapy, molecular diagnostics, and research. The methodologies for virus purification have to be both efficient and capable of preserving the integrity and infectivity of the virus, if needed. Techniques such as ultracentrifugation, filtration, and chromatography are commonly used. The market for virus purification includes consumables, such as reagents and kits, as well as equipment designed to facilitate the purification process. The industry is driven by advancements in biopharmaceuticals, an increased focus on vaccine development, and research into viral vectors for therapeutic uses. The market caters to academic and research institutes, pharmaceutical and biotechnology companies, and other healthcare entities involved in the study and application of viruses.
Notable companies that operate within the virus purification market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Sartorius AG, and Danaher Corporation. These companies offer a range of products and services tailored to support the virus purification needs of researchers and healthcare professionals, while also investing in research and technological improvements to enhance purification techniques and outcomes. Show Less Read more